KLRS FY 2019 Earnings — Kalaris Therapeutics Inc Revenue & Financial Results | Market Cap Arena

KLRSKalaris Therapeutics Inc

$180M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$165,000-85.5% YoY

Gross Profit

$00.0% margin

Operating Income

-$27M-16182.4% margin

Net Income

-$24M-14447.9% margin

EPS (Diluted)

$-8.42

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$139M

Total Liabilities

$18M

Stockholders' Equity

$122M

Cash & Equivalents

$61M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$165,000	$1M	-85.5%
Gross Profit	$0	$0	—
Operating Income	-$27M	-$4M	-642.5%
Net Income	-$24M	-$2M	-881.0%